In this roundtable discussion during Advanced Therapies Week 2025, industry leaders explore how decentralized and centralized manufacturing can work together to improve patient access to life-saving therapies. Featuring Carol Houts, CCO of Germfree; Becky Cap, Senior VP of Biotherapies at Vitalant; Claudia Zylberberg, Co-founder of Kosten Digital; and Veerle D’Haenens, Global Therapy Innovations at Terumo BCT, the panel delves into strategies for optimizing efficiency while ensuring patients receive timely treatment.

The conversation highlights key challenges and opportunities in aligning manufacturing models with patient needs. The experts discuss innovative solutions for streamlining processes, maintaining quality standards, and fostering collaboration across the industry. By bridging the gap between decentralized and centralized manufacturing approaches, organizations can create flexible, scalable solutions that adapt to the evolving demands of advanced therapies.

Watch the full discussion to gain insights on how these strategies are shaping the future of biopharmaceutical manufacturing and driving meaningful progress in patient care.